Clinical Trial Update: A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma [Phase 3]

View source ↗

Summary

Phase 3 study investigating napabucasin plus nab-paclitaxel with gemcitabine in adult metastatic pancreatic adenocarcinoma; trial completed with posted results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)
• napabucasin (napabucasin)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Carcinoma, Pancreatic Ductal | Phase 3 | Status: COMPLETED | Results posted: 2021-06-10